Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
- Institution
- Rockefeller University, NY
- Principal investigator
- Gabriel D Victora
- Funding
- $797K
- Duration
- 2022–2027
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Generation of high affinity antibodies in germinal centers (GCs) is a critical step in a wide variety of clinically relevant processes, from protection against pathogens by prior infection or vaccination to the development of allergies and autoimmune diseases. Antibody affinity maturation follows a prototypical Darwinian framework, in which GC B cells introduce random mutations into the antigen-binding portions of their immunoglobulin (Ig) genes, generating variations in affinity within their progeny. Rare B cells that acquire affinity-increasing mutation are then selectively expanded within the GC population, thus increasing the average affinity of GC B cells as a whole, in a process we refer to as positive selection. Despite decades of work, the precise cellular mechanisms of positive selection—in other words, how GCs “pick out” B cells with the highest affinity—remains a topic of debate. More than 10 years ago, we provided the first in vivo evidence in mice for a role for T follicular helper (Tfh) cells as arbiters of this selective process. In our model, Tfh cells would sense how much peptide a B cell could present on its surface (which in turn depended on the B cell’s affinity), providing help selectively to the highest-affinity B cells. However, despite accumulating functional evidence for this model, selective delivery of T cell help to B cells based on their affinity has never been directly demonstrated in physiological settings. To achieve this, we developed LIPSTIC, a method that allows us to directly record T cell help to B cells with great precision in vivo. In Aim 1 of this project, we propose to use LIPSTIC as a means to directly test the T cell help model in classic hapten-carrier induced GC selection models. In Aim 2, we will follow up on this by testing our findings from mouse LIPSTIC in human vaccine-induced GCs. In Aim 3, we use the original LIPSTIC in conjunction with two novel versions on this strategy to investigate the dynamics of multi-antigen driven selection in influenza-induced GCs.
LOADING MOONBASE SCORE
Questions for Rockefeller University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Rockefeller University43
Molecular control of germinal center selection and affinity maturation
Gabriel D Victora · $542K · 2018–2029
- NIH · Rockefeller UniversityReviewed
Inferring the rules of antibody evolution using replicated germinal centers
Gabriel D Victora · $812K · 2024–2029
- NIH · Rockefeller UniversityReviewed
Clonal Dynamics of the antibody response
Gabriel D Victora · $609K · 2017–2026